梯瓦制药

20.03
-0.01
-0.05%
TEVA
高 20.05开 20.00量 820.44万股总市值 229.77亿
低 19.77换 0.72%额 1.64亿市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
梯瓦制药(TEVA)
10-06 18:15  
$梯瓦制药(TEVA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-25-003465  Act: 34  Size: 7 KB 网页链接
用户头像
梯瓦制药(TEVA)
09-13 04:15  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0000902664-25-004073  Act: 33  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
09-10 04:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-113800  Size: 4 KB 网页链接
用户头像
梯瓦制药(TEVA)
08-07 00:15  
$梯瓦制药(TEVA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-002100  Act: 34  Size: 11 KB 网页链接
用户头像
梯瓦制药(TEVA)
08-06 04:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-102992  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
08-06 04:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-102977  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
08-02 04:15  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0001973379-25-000209  Act: 33  Size: 4 KB 网页链接
用户头像
梯瓦制药(TEVA)
08-02 04:05  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0001973379-25-000208  Act: 33  Size: 4 KB 网页链接
用户头像
梯瓦制药(TEVA)
07-31 04:15  
$梯瓦制药(TEVA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-169296  Act: 34  Size: 13 MB 网页链接
用户头像
梯瓦制药(TEVA)
07-30 19:15  
$梯瓦制药(TEVA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001171843-25-004808  Act: 34  Size: 825 KB 网页链接
用户头像
梯瓦制药(TEVA)
07-22 21:35  
$梯瓦制药(TEVA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-25-002442  Act: 34  Size: 10 KB 网页链接
用户头像
梯瓦制药(TEVA)
07-18 00:05  
$梯瓦制药(TEVA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-25-002400  Act: 34  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-17 04:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-086697  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-13 04:25  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0001973379-25-000186  Act: 33  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:35  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083777  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:25  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083749  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:25  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083756  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:25  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083765  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:25  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083769  Size: 9 KB 网页链接
用户头像
梯瓦制药(TEVA)
06-10 04:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-083706  Size: 9 KB 网页链接